Menu

News Releases

NEWS

Abattis Provides Comprehensive Update
June 20, 2020    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / June 17, 2020 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to provide a comprehensive corporate and operational update.
Abattis Provides Update on Trading Halt and Corporate Developments
Nov 8, 2019    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / Nov 8th, 2019 / Abattis Bioceuticals Corp (the “Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) November 8, 2019 / Abattis Bioceuticals Corp. (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) announces the following updates on recent developments related to Abattis since the trading of the Company’s common shares on the Canadian Stock Exchange (the “CSE”) was halted on February 4, 2019 (the “Halt”).
Abattis Announces Successful Closing of Pro Natura Acquisition
May 21, 2019    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / May 21st, 2019 / Abattis Bioceuticals Corp (the “Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its news release dated April 2nd, 2019, the Company’s wholly-owned subsidiary, 1185277 B.C. Ltd. (the “Acquisition Subsidiary”) has successfully closed the acquisition (the “Acquisition”) of Pro Natura BV (“Pro Natura”).
Abattis Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates
VANCOUVER, BRITISH COLUMBIA / January 17, 2019 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the temporary order from the British Columbia Securities Commission (“BCSC”), issued on November 26, 2018 (the “Order”), has not been extended against Abattis.
Abattis Provides Update on Trading Halt and Announces Management Conference Call
VANCOUVER, BRITISH COLUMBIA / January 17, 2019 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the temporary order from the British Columbia Securities Commission (“BCSC”), issued on November 26, 2018 (the “Order”), has not been extended against Abattis.